PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA

Abed Rahman Kawakibi; Sharon Gardner; Andrew Chi; Sylvia Kurz; Patrick Wen; Isabel Arrillaga-Romany; Tracy Batchelor; Nicholas Butowski; Ashley Sumrall; Nicole Shonka; Rebecca Harrison; John DeGroot; Minesh Mehta; Yazmin Odia; Matthew Hall; Doured Daghistani; Timothy Cloughesy; Benjamin Ellingson; Yoshie Umemura; Jonathan Schwartz; Vivekanand Yadav; Rodrigo Cartaxo; Zachary Miklja; Amy Bruzek; Ruby Siada; Brendan Mullan; Stefanie Stallard; Ashwath Muruganand; Kyle Wierzbicki; Alyssa Paul; Ian Wolfe; Chandan Kumar-Sinha; Bernard Marini; Marcia Leonard; Hugh Garton; Rajen Mody; Patricia Robertson; Krystal Merdinger; Rohinton Tarapore; Wolfgang Oster; Joshua Allen; Carl Koschmann

doi:10.1093/neuonc/noz175.773

PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA

Abed Rahman Kawakibi, Sharon Gardner, Andrew Chi, Sylvia Kurz, Patrick Wen, Isabel Arrillaga-Romany, Tracy Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca Harrison, John DeGroot, Minesh Mehta, Yazmin Odia, Matthew Hall, Doured Daghistani, Timothy Cloughesy, Benjamin Ellingson, Yoshie Umemura, Jonathan SchwartzVivekanand Yadav, Rodrigo Cartaxo, Zachary Miklja, Amy Bruzek, Ruby Siada, Brendan Mullan, Stefanie Stallard, Ashwath Muruganand, Kyle Wierzbicki, Alyssa Paul, Ian Wolfe, Chandan Kumar-Sinha, Bernard Marini, Marcia Leonard, Hugh Garton, Rajen Mody, Patricia Robertson, Krystal Merdinger, Rohinton Tarapore, Wolfgang Oster, Joshua Allen, Carl Koschmann

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1093/neuonc/noz175.773
State	Published - Nov 11 2019
Event	Neuro-oncology - Duration: Nov 11 2019 → …

Conference

Conference	Neuro-oncology
Period	11/11/19 → …

Disciplines

Oncology
Pathology
Medicine and Health Sciences

Access to Document

10.1093/neuonc/noz175.773License: Unspecified

Cite this

Kawakibi, A. R., Gardner, S., Chi, A., Kurz, S., Wen, P., Arrillaga-Romany, I., Batchelor, T., Butowski, N., Sumrall, A., Shonka, N., Harrison, R., DeGroot, J., Mehta, M., Odia, Y., Hall, M., Daghistani, D., Cloughesy, T., Ellingson, B., Umemura, Y., ... Koschmann, C. (2019). PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA. Neuro-oncology. https://doi.org/10.1093/neuonc/noz175.773

Kawakibi, AR, Gardner, S, Chi, A, Kurz, S, Wen, P, Arrillaga-Romany, I, Batchelor, T, Butowski, N, Sumrall, A, Shonka, N, Harrison, R, DeGroot, J, Mehta, M , Odia, Y , Hall, M , Daghistani, D, Cloughesy, T, Ellingson, B, Umemura, Y, Schwartz, J, Yadav, V, Cartaxo, R, Miklja, Z, Bruzek, A, Siada, R, Mullan, B, Stallard, S, Muruganand, A, Wierzbicki, K, Paul, A, Wolfe, I, Kumar-Sinha, C, Marini, B, Leonard, M, Garton, H, Mody, R, Robertson, P, Merdinger, K, Tarapore, R, Oster, W, Allen, J & Koschmann, C 2019, 'PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA', Neuro-oncology, 11/11/19. https://doi.org/10.1093/neuonc/noz175.773

@conference{e33ed12dd61745299c7a4c472284fecc,

title = "PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA",

author = "Kawakibi, {Abed Rahman} and Sharon Gardner and Andrew Chi and Sylvia Kurz and Patrick Wen and Isabel Arrillaga-Romany and Tracy Batchelor and Nicholas Butowski and Ashley Sumrall and Nicole Shonka and Rebecca Harrison and John DeGroot and Minesh Mehta and Yazmin Odia and Matthew Hall and Doured Daghistani and Timothy Cloughesy and Benjamin Ellingson and Yoshie Umemura and Jonathan Schwartz and Vivekanand Yadav and Rodrigo Cartaxo and Zachary Miklja and Amy Bruzek and Ruby Siada and Brendan Mullan and Stefanie Stallard and Ashwath Muruganand and Kyle Wierzbicki and Alyssa Paul and Ian Wolfe and Chandan Kumar-Sinha and Bernard Marini and Marcia Leonard and Hugh Garton and Rajen Mody and Patricia Robertson and Krystal Merdinger and Rohinton Tarapore and Wolfgang Oster and Joshua Allen and Carl Koschmann",

note = "Abstract. ONC201, the first bitopic DRD2 antagonist for clinical oncology, has shown efficacy in H3 K27M-mutant glioma. We performed an integrated preclinical; Neuro-oncology ; Conference date: 11-11-2019",

year = "2019",

month = nov,

day = "11",

doi = "10.1093/neuonc/noz175.773",

language = "American English",

}

TY - CONF

T1 - PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA

AU - Kawakibi, Abed Rahman

AU - Gardner, Sharon

AU - Chi, Andrew

AU - Kurz, Sylvia

AU - Wen, Patrick

AU - Arrillaga-Romany, Isabel

AU - Batchelor, Tracy

AU - Butowski, Nicholas

AU - Sumrall, Ashley

AU - Shonka, Nicole

AU - Harrison, Rebecca

AU - DeGroot, John

AU - Mehta, Minesh

AU - Odia, Yazmin

AU - Hall, Matthew

AU - Daghistani, Doured

AU - Cloughesy, Timothy

AU - Ellingson, Benjamin

AU - Umemura, Yoshie

AU - Schwartz, Jonathan

AU - Yadav, Vivekanand

AU - Cartaxo, Rodrigo

AU - Miklja, Zachary

AU - Bruzek, Amy

AU - Siada, Ruby

AU - Mullan, Brendan

AU - Stallard, Stefanie

AU - Muruganand, Ashwath

AU - Wierzbicki, Kyle

AU - Paul, Alyssa

AU - Wolfe, Ian

AU - Kumar-Sinha, Chandan

AU - Marini, Bernard

AU - Leonard, Marcia

AU - Garton, Hugh

AU - Mody, Rajen

AU - Robertson, Patricia

AU - Merdinger, Krystal

AU - Tarapore, Rohinton

AU - Oster, Wolfgang

AU - Allen, Joshua

AU - Koschmann, Carl

N1 - Abstract. ONC201, the first bitopic DRD2 antagonist for clinical oncology, has shown efficacy in H3 K27M-mutant glioma. We performed an integrated preclinical

PY - 2019/11/11

Y1 - 2019/11/11

UR - http://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi186/30633679/noz175.773.pdf

U2 - 10.1093/neuonc/noz175.773

DO - 10.1093/neuonc/noz175.773

M3 - Presentation

T2 - Neuro-oncology

Y2 - 11 November 2019

ER -

PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA

Conference

Disciplines

Access to Document

Other files and links

Cite this